Sponge contraceptive returning to market

	Tweet

A contraceptive sponge for women is returning to the U.S. market for the first time in a decade, the manufacturer said on Friday.

The over-the-counter Today Sponge will start reappearing on store shelves this summer, maker Allendale Pharmaceuticals said. The company won the needed government clearance of its production facilities, Food and Drug Administration spokeswoman Susan Cruzan confirmed.

The earlier producer, American Home Products, stopped making the sponge in late 1994 when it encountered manufacturing problems and decided it was too costly to upgrade its plant. American Home Products is now Wyeth.

The sponge was made famous by the television comedy “Seinfeld,” when the character Elaine hoarded the devices once they were no longer made. She then used the birth control method only when she deemed a man “spongeworthy.”

That episode, and repeated re-runs, raised awareness of the product. Allendale, which bought rights to the Today Sponge in 1998, received daily inquiries and kept an e-mail list of about 9,000 women interested in the sponge’s return, said Allendale President and Chief Executive Gene Detroyer.

The sponge is a round, disposable device soaked with spermicide that is inserted into the vagina to block a woman’s cervix. One sponge can be used for 24 hours through repeated acts of sexual intercourse. The sponge does not contain hormones, as birth control pills do.

Three sponges will cost between $7.49 and $8.99, Detroyer said.

Studies of more than 1,800 women found the sponge was between 89 percent and 91 percent effective at preventing pregnancy when used as directed. The effectiveness rate is similar to that of the male condom, Allendale said.

More than 250 million sponges were sold between 1983 and 1994, when the Today Sponge was previously available. Allendale plans to make between 10 million and 15 million sponges during the next year and probably double production in the second year, Detroyer said.

The Today Sponge was released in Canada in 2003.

Allendale Pharmaceuticals is a privately held firm based in New Jersey

RELATED STORIES:
FDA chief to meet with top lawmaker about Vioxx   Australia’s medicines regulator close to decision on herceptin   FDA: No increased cardiovascular risk with heartburn drugs   Drug maker packs red-wine-like compound in pill   FDA Says None of Chiron Influenza Vaccine Safe for Use   FDA Adds Warnings For Painkiller Bextra   Short-Term Celebrex Safe Against Cirrhosis   Lamictal cuts effectiveness of the pill   FDA Approves Relenza for Prevention of Seasonal Flu   With Vioxx gone, pain drug prices jump   FDA Advisers Vote Against Female Sex Drug   Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]